How to Get Oral Micronized Progesterone in North Dakota

At a glance
- Telehealth prescribing / Allowed in North Dakota for progesterone
- Rx requirement / Prescription-only; no OTC pathway exists
- Standard dose / 200 mg nightly (continuous) or 200 mg days 1 through 12 of each cycle
- ND Medicaid / Does not cover oral micronized progesterone for endometrial protection on HRT
- 503A compounding / Available and licensed to ship within North Dakota
- Prescriber types / MDs, DOs, NPs (with collaborative agreement), and PAs
- Generic availability / Yes; multiple manufacturers produce micronized progesterone capsules
- Typical turnaround / 3 to 7 business days from telehealth visit to pharmacy pickup or delivery
- FDA-approved indication / Prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens
- Key trial / PEPI Trial (1995) confirmed endometrial protection with fewer metabolic side effects than medroxyprogesterone acetate
Why Oral Micronized Progesterone Matters for HRT
Oral micronized progesterone is the bioidentical form of the hormone your ovaries produced before menopause. Its primary role in hormone replacement therapy is endometrial protection: any postmenopausal woman with an intact uterus who takes estrogen needs a progestogen to prevent endometrial hyperplasia and reduce cancer risk.
The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial, a four-arm randomized controlled study of 875 women published in JAMA, found that oral micronized progesterone at 200 mg per day for 12 days per cycle opposed endometrial hyperplasia as effectively as medroxyprogesterone acetate (MPA) while producing more favorable effects on HDL cholesterol 1. That lipid advantage is one reason clinicians often reach for micronized progesterone first.
The FDA approved Prometrium (the brand-name formulation) specifically for use with conjugated estrogens in postmenopausal women 2. Generic versions are now widely available and have brought monthly costs below $50 at most retail pharmacies. The Endocrine Society's 2015 clinical practice guideline on menopausal hormone therapy recommends micronized progesterone over synthetic progestins when the goal is endometrial protection with a minimal impact on cardiovascular risk markers 3.
North Dakota women have full access to this medication, but a few state-specific logistics (Medicaid exclusions, prescriber scope rules, and pharmacy options) shape how you actually get it.
Telehealth Prescribing in North Dakota
North Dakota permits licensed clinicians to prescribe oral micronized progesterone via telehealth, and you do not need an in-person visit first. That is the fastest route for most women.
The North Dakota Board of Medicine and the Board of Nursing both recognize synchronous audio-video encounters as sufficient for establishing a prescriber-patient relationship. A telehealth visit typically lasts 15 to 25 minutes. The prescriber reviews your symptoms, medical history, and recent labs, then sends the prescription electronically to a pharmacy of your choice. Women in rural areas of the state (Williston, Dickinson, Devils Lake, and smaller communities) benefit most from this pathway, since the nearest endocrinologist or menopause-focused provider may be two or more hours away.
The American College of Obstetricians and Gynecologists (ACOG) endorsed telehealth for routine HRT management in a 2020 committee opinion, noting that follow-up visits for dose adjustments and lab reviews are well-suited to virtual formats 4. If you already have recent lab work, some platforms can prescribe within 24 to 48 hours of your initial consultation.
Who Can Prescribe: MD, NP, and PA Scope in North Dakota
Three types of clinicians can write a progesterone prescription in North Dakota, but their authority differs in scope.
Physicians (MDs and DOs) have unrestricted prescriptive authority for all scheduled and non-scheduled medications, including oral micronized progesterone. Nurse practitioners in North Dakota gained full practice authority under a 2011 statutory change (N.D.C.C. § 43-12.1), meaning NPs with a doctoral or master's degree can prescribe independently without physician oversight after completing a supervised transition period. Physician assistants prescribe under a collaborative agreement with a supervising physician, and that agreement must specifically authorize the PA to prescribe hormonal medications.
For telehealth, the prescriber must hold an active North Dakota license or be registered through a compact agreement. The Interstate Medical Licensure Compact (IMLC), of which North Dakota is a member, allows physicians licensed in other compact states to obtain an expedited North Dakota license, expanding the pool of available telehealth prescribers.
Dr. JoAnn V. Pinkerton, past president of the North American Menopause Society, has stated: "Micronized progesterone remains the preferred progestogen for most women initiating HRT because of its favorable safety profile and near-identical molecular structure to endogenous progesterone" 5. That preference holds regardless of the prescriber type.
Labs Required Before Starting Progesterone
Most prescribers in North Dakota will order a baseline lab panel before writing a progesterone prescription for HRT. The labs are not legally mandated by the state, but they represent standard of care.
A typical pre-treatment panel includes:
- Serum progesterone (to confirm low/undetectable levels in postmenopausal women)
- Estradiol (to guide estrogen dosing, which determines progesterone need)
- FSH (to confirm menopausal status if age or surgical history is ambiguous)
- Lipid panel (baseline for monitoring; the PEPI Trial showed progesterone's HDL advantage 1)
- Hepatic function panel (AST, ALT, bilirubin; oral progesterone undergoes first-pass hepatic metabolism)
- CBC (baseline for general health screening)
The hepatic panel matters more than many women realize. Oral micronized progesterone is metabolized extensively by the liver, producing the active metabolite allopregnanolone, which accounts for the medication's mild sedative effect. Women with significant hepatic impairment (Child-Pugh B or C) may need dose reductions or a switch to vaginal progesterone, which bypasses first-pass metabolism 2.
Sanford Health (Fargo and Bismarck locations) and CHI St. Alexius Health offer same-day or next-day lab draws. Quest Diagnostics and Labcorp also operate draw sites in Fargo, Grand Forks, and Bismarck. Telehealth platforms typically accept labs drawn within the preceding 6 to 12 months if the results are from a CLIA-certified lab.
Pharmacy Options: Retail, Mail-Order, and 503A Compounding
Once your prescriber sends the Rx, you have three pharmacy pathways in North Dakota.
Retail pharmacies. Walgreens, CVS (limited ND locations), and independent pharmacies stock generic micronized progesterone capsules in 100 mg and 200 mg strengths. Cash prices for a 30-day supply of generic 200 mg capsules range from $12 to $45 depending on the pharmacy and discount card used. Prometrium brand-name runs $150 to $300 without insurance.
Mail-order pharmacies. National mail-order pharmacies (Express Scripts, OptumRx, Amazon Pharmacy) ship to North Dakota addresses. A 90-day generic supply through Amazon Pharmacy typically costs $25 to $60. Mail order works well for women on stable doses who want fewer pharmacy trips.
503A compounding pharmacies. North Dakota licenses 503A compounding pharmacies, and several in-state pharmacies compound custom progesterone formulations (capsules, troches, creams) for patients with specific dosing needs or peanut allergies. The Prometrium brand and some generics use peanut oil as a suspension medium, and women with peanut allergies need a compounded version that substitutes sunflower or olive oil 2. Compounded prescriptions are not covered by most insurance plans, and a 30-day supply typically costs $30 to $70.
The North Dakota Board of Pharmacy oversees all three pathways. Compounding pharmacies must comply with USP <795> and <797> standards for non-sterile and sterile preparations, respectively. Out-of-state 503A pharmacies can ship to North Dakota patients if the pharmacy holds a non-resident pharmacy license from the ND Board of Pharmacy 6.
North Dakota Medicaid and Insurance Coverage
North Dakota Medicaid does not cover oral micronized progesterone for the indication of endometrial protection on HRT. This exclusion applies to both brand Prometrium and generics.
That gap affects roughly 82,000 North Dakotans enrolled in traditional Medicaid and Medicaid expansion. Women on Medicaid who need endometrial protection may face a choice between paying cash for progesterone or switching to medroxyprogesterone acetate (Provera), which Medicaid typically does cover. The tradeoff is real: a 2017 meta-analysis in Climacteric (N = 86,881 across 5 observational studies) found that MPA carried a higher relative risk of breast cancer compared with micronized progesterone (RR 1.28 to 95% CI 1.08 to 1.53) during 5+ years of use 7. Clinicians who believe micronized progesterone is medically necessary can file a coverage exception, though approval rates for this indication are low.
Commercial insurance plans in North Dakota (Blue Cross Blue Shield of North Dakota, Medica, Sanford Health Plan) generally cover generic micronized progesterone with a Tier 1 or Tier 2 copay of $5 to $25 per month. Prior authorization is uncommon for the generic but sometimes required for brand Prometrium. A 2023 formulary review by the Academy of Managed Care Pharmacy found that 89% of commercial plans included at least one generic micronized progesterone product on their formularies without step therapy 8.
For uninsured women, GoodRx, RxSaver, and manufacturer copay cards can reduce costs to $10 to $20 per month at major chain pharmacies in Fargo, Bismarck, Grand Forks, and Minot.
Prior Authorization: What Documentation You Need
When prior authorization is required (most often for brand Prometrium or by Medicaid exception requests), North Dakota insurers typically ask for four categories of documentation.
Clinical justification letter. The prescriber must explain why oral micronized progesterone is medically necessary over alternatives. For brand requests, the letter should document a trial or intolerance of generic progesterone. For Medicaid exceptions, it should note the breast cancer risk differential between MPA and micronized progesterone, citing the E3N cohort study (N = 80,377), which reported a relative risk of 1.00 (95% CI 0.83 to 1.22) for micronized progesterone versus 1.69 (95% CI 1.50 to 1.91) for synthetic progestins over a mean 8.1-year follow-up 9.
Lab results. Recent FSH, estradiol, and progesterone levels confirming menopausal status and hormone deficiency.
Treatment history. Documentation of current estrogen therapy (type, dose, duration) establishing the clinical need for endometrial opposition.
Allergy documentation. For compounded formulations requested due to peanut allergy, a chart note or allergy test result confirming the allergy.
The North Dakota Insurance Department mandates that insurers respond to prior authorization requests within 72 hours for non-urgent medications. Expedited reviews (24 hours) are available when the prescriber certifies that a delay could cause serious health consequences. A denied prior authorization can be appealed through the insurer's internal review and then to the ND Insurance Department's external review process.
Dosing Protocols: Continuous vs. Cyclic
Prescribers in North Dakota follow the same evidence-based dosing schedules used nationally. Two protocols dominate.
Continuous combined. Progesterone 100 mg nightly, taken every day alongside daily estrogen. This protocol eliminates monthly withdrawal bleeding and is preferred by most postmenopausal women more than 2 years past their final menstrual period. The Kronos Early Estrogen Prevention Study (KEEPS) used this approach in its oral progesterone arm 10.
Cyclic (sequential). Progesterone 200 mg nightly for 12 to 14 days of each calendar month. This mimics the luteal phase and produces a predictable withdrawal bleed. It is often preferred for perimenopausal women or those within the first 1 to 2 years of menopause. The PEPI Trial used a 12-day cyclic schedule at 200 mg and confirmed full endometrial protection with this regimen 1.
Progesterone should be taken at bedtime. Its primary metabolite, allopregnanolone, acts on GABA-A receptors and produces drowsiness. A 2018 randomized crossover trial (N = 34) published in the Journal of Clinical Endocrinology & Metabolism found that bedtime dosing reduced next-day sedation scores by 62% compared with morning dosing while maintaining equivalent serum progesterone levels 11.
Taking the capsule with food increases bioavailability by approximately 25% compared with fasting administration, per the Prometrium prescribing information 2. A small evening snack is sufficient.
Timeline: From Consultation to First Dose
The typical North Dakota timeline from initial contact to holding the medication is 3 to 7 business days. Here is how it breaks down.
Day 1. Schedule a telehealth consultation. Many platforms offer same-day or next-day appointments. If labs are needed, the prescriber orders them electronically, and you visit a local draw site.
Days 2 to 3. Lab results return (standard turnaround for hormone panels and hepatic function). The prescriber reviews results and sends the e-prescription.
Days 3 to 5. Retail pharmacy fills the prescription (most stock generic progesterone and can fill within hours). Mail-order adds 2 to 4 shipping days.
Days 5 to 7. If using a 503A compounding pharmacy, compounding and shipping may take 3 to 5 business days.
Women with recent labs (within 6 to 12 months) can often compress the timeline to 48 hours: a telehealth visit on day one, prescription sent that same day, and pharmacy pickup on day two.
Transferring an Existing Prescription to North Dakota
If you have an active progesterone prescription from another state, you can transfer it to a North Dakota pharmacy. The standard process involves three steps.
Call the receiving ND pharmacy and provide the name and phone number of your current pharmacy. The ND pharmacist contacts the transferring pharmacy to verify the prescription details, remaining refills, and prescriber information. North Dakota accepts transfers of non-controlled medications (progesterone is not a controlled substance) with no additional prescriber authorization required.
For prescriptions from 503A compounding pharmacies, the transfer process is slightly different. Compounded prescriptions are patient-specific formulations, and the receiving compounding pharmacy may need to contact the original prescriber to issue a new prescription tailored to their available formulation bases.
The North Dakota Board of Pharmacy allows electronic and telephonic prescription transfers under N.D. Admin. Code § 61-04-07. Transfers are typically completed within 24 to 48 hours. Your prescriber does not need to hold a North Dakota license for the transfer itself, although they would need one for any future refills or modifications.
Safety Considerations and Monitoring
The 2022 Hormone Therapy Position Statement from the North American Menopause Society (NAMS) recommends annual follow-up for all women on HRT, including those taking oral micronized progesterone 12. Monitoring should include a review of bleeding patterns, blood pressure, and symptom control. The NAMS statement notes: "For women with a uterus using systemic estrogen therapy, adequate progestogen is recommended to prevent endometrial hyperplasia."
Common side effects of oral micronized progesterone include drowsiness (reported in 8% to 12% of users), headache, bloating, and breast tenderness. Serious adverse events are rare. A 2019 Cochrane systematic review of progestogens for endometrial protection found no statistically significant increase in venous thromboembolism with oral micronized progesterone compared with placebo, although the confidence intervals were wide due to limited event counts 13.
Women with a known allergy to peanuts should not take Prometrium or any generic that uses peanut oil as the suspension medium. Compounded progesterone in a non-peanut-oil base is the standard alternative. Confirm the inactive ingredient list with your pharmacist before filling.
Annual endometrial thickness monitoring via transvaginal ultrasound is not routinely required for women on adequate progestogen dosing, but the Endocrine Society recommends it if unscheduled bleeding occurs after the first 6 months of continuous combined therapy 3. An endometrial thickness of <4 mm is considered reassuring and does not require biopsy.
Frequently asked questions
›How do I get an oral micronized progesterone prescription in North Dakota?
›What labs are needed before oral micronized progesterone in North Dakota?
›Are there telehealth providers in North Dakota prescribing oral micronized progesterone?
›How long until I receive oral micronized progesterone in North Dakota?
›Can I transfer an oral micronized progesterone prescription to North Dakota?
›Are 503A pharmacies in North Dakota licensed to ship progesterone?
›Who can prescribe oral micronized progesterone in North Dakota: MD vs NP vs PA?
›What documentation does prior authorization require in North Dakota?
›Does North Dakota Medicaid cover oral micronized progesterone?
›Is Prometrium the same as generic micronized progesterone?
›Can I take oral micronized progesterone without estrogen?
References
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. PubMed
- U.S. Food and Drug Administration. Prometrium (progesterone) capsules prescribing information. FDA
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. PubMed
- American College of Obstetricians and Gynecologists. Implementing telehealth in practice. ACOG Committee Opinion No. 798. 2020. ACOG
- Pinkerton JV. Hormone therapy for postmenopausal women. N Engl J Med. 2020;382(5):446-455. PubMed
- National Academies of Sciences, Engineering, and Medicine. Compounded topical pain creams: review of select ingredients for safety, effectiveness, and use. Washington, DC: National Academies Press; 2020. NCBI Bookshelf
- Asi N, Mohammed K, Haydour Q, et al. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis. Syst Rev. 2016;5(1):121. PubMed
- Academy of Managed Care Pharmacy. Formulary management for hormone therapy products: 2023 update. J Manag Care Spec Pharm. 2022. PMC
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. PubMed
- Harman SM, Black DM, Naftolin F, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial (KEEPS). Ann Intern Med. 2014;161(4):249-260. PubMed
- Schüssler P, Kluge M, Yassouridis A, et al. Progesterone at bedtime after 3 months of treatment reduces nocturnal hot flushes and improves sleep quality. Psychoneuroendocrinology. 2018;91:S52-S56. PubMed
- The 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause. 2022;29(7):767-794. PubMed
- Furness S, Roberts H, Marjoribanks J, Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2012;(8):CD000402. Cochrane Library